Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Vogelmeier

Showing results (21-30 of 158) with videos related to

Pageof 16
Sort By:
Respiratory Medicine|March 29, 2014
Understanding the GOLD 2011 Strategy as applied to a real-world COPD populationJørgen Vestbo, Claus Vogelmeier, Mark Small, et al.
Annals of Internal Medicine|October 19, 2011
Inhaled long-acting β-agonists versus anticholinergics in older patients with chronic obstructive pulmonary diseaseLeonardo M Fabbri, Claus Vogelmeier, Klaus F Rabe
International Journal of Chronic Obstructive Pulmonary Disease|February 29, 2012
Guideline-based survey of outpatient COPD management by pulmonary specialists in GermanyThomas Glaab, Claus Vogelmeier, Andreas Hellmann, et al.
European Journal of Internal Medicine|September 6, 2024
Managing and discharging COPD patients hospitalized because of an exacerbation of respiratory symptoms: An opportunity to improve outcomesAlvar Agusti, Bartolome R Celli, Leonardo Fabbri, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 13, 2022
New Perspectives on Chronic Obstructive Pulmonary DiseaseBartolome R Celli, Dave Singh, Claus Vogelmeier, et al.
Respiration; International Review of Thoracic Diseases|August 19, 2004
Exposure of differentiated airway epithelial cells to volatile smoke in vitroChristoph Beisswenger, Juliane Platz, Carola Seifart, et al.
Journal of Virological Methods|July 6, 2004
Inhibition of NF-kappaB mediated inflammation by siRNA expressed by recombinant adeno-associated virusOlaf Pinkenburg, Juliane Platz, Christoph Beisswenger, et al.
BMC Pulmonary Medicine|October 5, 2014
Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease--a randomized, multicenter, double-blind, placebo-controlled studyHenrik Watz, Felix Krippner, Anne Kirsten, et al.
Respiratory Medicine|July 31, 2025
Parametric estimation of age-, sex-, and spirometry grade-specific mortality in a cohort of COPD patients from Germany: Results from COSYCONETTobias Niedermaier, Peter Alter, Rudolf Jörres, et al.
Therapeutic Advances in Respiratory Disease|July 2, 2011
Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary diseaseClaus Vogelmeier, Helgo Magnussen, Craig LaForce, et al.
Pageof 16

Showing results (21-30 of 158) with videos related to

Sort By:
Pageof 16
Respiratory Medicine|March 29, 2014
Understanding the GOLD 2011 Strategy as applied to a real-world COPD populationJørgen Vestbo, Claus Vogelmeier, Mark Small, et al.
Annals of Internal Medicine|October 19, 2011
Inhaled long-acting β-agonists versus anticholinergics in older patients with chronic obstructive pulmonary diseaseLeonardo M Fabbri, Claus Vogelmeier, Klaus F Rabe
International Journal of Chronic Obstructive Pulmonary Disease|February 29, 2012
Guideline-based survey of outpatient COPD management by pulmonary specialists in GermanyThomas Glaab, Claus Vogelmeier, Andreas Hellmann, et al.
European Journal of Internal Medicine|September 6, 2024
Managing and discharging COPD patients hospitalized because of an exacerbation of respiratory symptoms: An opportunity to improve outcomesAlvar Agusti, Bartolome R Celli, Leonardo Fabbri, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 13, 2022
New Perspectives on Chronic Obstructive Pulmonary DiseaseBartolome R Celli, Dave Singh, Claus Vogelmeier, et al.
Respiration; International Review of Thoracic Diseases|August 19, 2004
Exposure of differentiated airway epithelial cells to volatile smoke in vitroChristoph Beisswenger, Juliane Platz, Carola Seifart, et al.
Journal of Virological Methods|July 6, 2004
Inhibition of NF-kappaB mediated inflammation by siRNA expressed by recombinant adeno-associated virusOlaf Pinkenburg, Juliane Platz, Christoph Beisswenger, et al.
BMC Pulmonary Medicine|October 5, 2014
Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease--a randomized, multicenter, double-blind, placebo-controlled studyHenrik Watz, Felix Krippner, Anne Kirsten, et al.
Respiratory Medicine|July 31, 2025
Parametric estimation of age-, sex-, and spirometry grade-specific mortality in a cohort of COPD patients from Germany: Results from COSYCONETTobias Niedermaier, Peter Alter, Rudolf Jörres, et al.
Therapeutic Advances in Respiratory Disease|July 2, 2011
Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary diseaseClaus Vogelmeier, Helgo Magnussen, Craig LaForce, et al.
Pageof 16